Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Psychother Psychosom. 2004 Jul-Aug;73(4):207-15.

    Drug-induced depression: a systematic review to inform clinical practice.

    Source

    Department of Community Health Sciences, Faculty of Medicine, University of Calgary, Calgary, AB, Canada. patten@ucalgary.ca

    Abstract

    BACKGROUND:

    Certain medications may contribute to the etiology of depressive symptoms and disorders. Research in this area, however, has been hampered by methodological and conceptual problems. This review had two objectives: to identify evidence linking medical drugs to depressive symptoms and disorders, and to summarize this evidence in a clinically meaningful way.

    METHODS:

    Electronic literature searches were performed and studies were reviewed with reference to critical methodological features.

    RESULTS:

    No medications causing the typical major depressive syndrome were identified. Evidence was found linking corticosteroids, interferon-alpha, interleukin-2, gonadotropin-releasing hormone agonists, mefloquine, progestin-releasing implanted contraceptives and propranolol to the etiology of atypical depressive syndromes.

    CONCLUSIONS:

    A small number of drugs have been shown capable of inducing depressive symptoms. Drug-induced depression appears to differ symptomatically from classical major depression.

    Copyright 2004 S. Karger AG, Basel

    Comment in

    PMID:
    15184715
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for S. Karger AG, Basel, Switzerland

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk